|
5-Bromo-2′-deoxyuridine?? 5-溴-2′-脫氧尿苷 Synonym?: BUdR | 5-Bromo-1-(2-deoxy-β-D-ribofuranosyl)uracil | 5-BrdU | 5-溴-2′-脫氧尿苷 ?? | 5-Bromouracil deoxyriboside | 5-溴脫氧尿嘧啶核苷 | 5-溴, Descriptions: ?? Brdu,中文全名5-溴脫氧尿嘧啶核苷,為胸腺嘧啶的衍生物,可代替胸腺嘧啶在DNA合成期(S期),活體注射或細胞培養(yǎng)加入,而后利用抗Brdu單克隆抗體,ICC染色,顯示增殖細胞。同時結(jié)合其它細胞標記物,雙重染色,可判斷增殖細胞的種類,增殖速度,對研究細胞動力學有重要意義。 ??目前常用的細胞增殖標記物有4種,Brdu (5-bromo-2--deoxyuridine), DNA polymerase α,PCNA (Proliferating cell nuclear antigen),Ki-67 等。因組織細胞內(nèi)無內(nèi)源性Brdu存在,所以Brdu應用較廣。Brdu,中文全名5-溴脫氧尿嘧啶核苷,為胸腺嘧啶的衍生物,可代替胸腺嘧啶在DNA合成期(S期),活體注射或細胞培養(yǎng)加入,而后利用抗Brdu單克隆抗體,ICC染色,顯示增殖細胞。同時結(jié)合其它細胞標記物,雙重染色,可判斷增殖細胞的種類,增殖速度,對研究細胞動力學有重要意義。 APPLICATIONS: BrdU is selectively incorporated into cell DNA at the S phase of cell cycle. The use of BrdU as a thymidine analog has made possible the identification of DNA synthesis in suspensions of cells, cell smears and tissue sections. The incorporation of BrdU into DNA in place of thymidine is discussed by A.L. Givan.5 BrdU at 0.16 to 500 mg/mL of cell culture media produced inhibition of growth of KD cells (rabbit kidney cells). Effective inhibition at concentrations greater than 1.0 mg/mL was observed.6 It is incorporated, in vivo,by injecting 10-100 mg/kg at 10 mg/mL in saline intraperitoneally.7 It is also incorporated into bone marrow cells in culture at a final concentration of 10 mM at 37EC for one hour. For incorporation to occur, the BrdU must be phosphorylated in the cell by thymidine kinase.8 FITC-conjugated second antibodies can be used with antibodies specific for BrdU (Sigma product B2531) which will make "new" DNA fluoresce green; denatured DNA can be stained with propidium iodide and will fluoresce red. 技術(shù)參數(shù): Product Name?? 5-Bromo-2′-deoxyuridine,≥99% (HPLC) Product Number:B5002 Product Brand:Sigma CAS Number:59-14-3 Molecular Formula:C9H11BrN2O5 Molecular Weight:307.10 ???? ? Storage Temp: APPEARANCE:WHITE TO OFF-WHITE POWDER SOLUBILITY:CLEAR COLORLESS TO VERY FAINT YELLOW SOLUTION AT 50MG/ML OF 1MAMMONIUM HYDROXIDE UV-VIS SPECTRUM:EMM = 8.9 TO 9.2 AT LAMBDA MAX279 TO 280NM AT PH1.0 PURITY BY HPLC:99% MINIMUM SOLUBILITY / SOLUTION STABILITY: Sigma routinely tests the solubility at 50 mg/mL in Ordering Information
|
BRDU 5-溴-2′-脫氧尿苷 5-Bromo-2′-deoxyuridine
作者:翌圣生物科技(上海)股份有限公司 2010-02-18T00:00 (訪問量:9017)
翌圣生物科技(上海)股份有限公司 商家主頁
地 址: 上海市浦東新區(qū)天雄路166弄一號樓三層南單元
聯(lián)系人: 李自轉(zhuǎn)
電 話: 400-6111-883、021-34615995-8075
傳 真: 021-34615995-188
Email:lizizhuan@yeasen.com
相關(guān)咨詢
國函批復!上海辰山國家植物園設(shè)立,國產(chǎn)試劑支撐植物多樣性科研攻關(guān) (2026-07-03T00:00 瀏覽數(shù):2327)
上新|GMP級重組人GM-CSF,適配細胞治療、疫苗研發(fā),全流程合規(guī)更省心 (2026-07-02T00:00 瀏覽數(shù):3406)
上新|GMP級重組人IL-18,免疫細胞增效核心原料 (2026-07-02T00:00 瀏覽數(shù):3382)
100+ 種不同細胞全面驗證— 翌圣生物轉(zhuǎn)染試劑:高效低毒的國產(chǎn)優(yōu)選 (2026-07-02T00:00 瀏覽數(shù):3400)
科研人集合啦!曬出你的qPCR高光時刻 (2026-07-02T00:00 瀏覽數(shù):3442)
重磅成果!翌圣生物聯(lián)合中檢院發(fā)表支原體檢測技術(shù)研究論文 (2026-06-30T00:00 瀏覽數(shù):4655)
聚焦單細胞與空間組學前沿,翌圣生物亮相第二屆西部單細胞與空間組學論壇 (2026-06-30T00:00 瀏覽數(shù):4757)
從機制到轉(zhuǎn)化:2026年5月高分文獻核心進展與趨勢解讀 (2026-06-26T00:00 瀏覽數(shù):7609)
Science 重磅成果:西湖大學團隊攻克共價蛋白藥物核心瓶頸,建立通用高通量速效蛋白篩選平臺 (2026-06-26T00:00 瀏覽數(shù):7422)
類器官·血管生成·侵襲·成瘤 | 基質(zhì)膠應用案例合集 (2026-06-26T00:00 瀏覽數(shù):7543)
